Want to see BIO.B full AI Analyst Report?
Bio-Rad Laboratories, Inc. Class B (BIO.B) Stock Forecast & Price Target
BIO.B Analyst Ratings
There are no analyst ratings in the last 3 months.
BIO.B Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | $392 | hold | 2.56%Upside | Initiated | 10/23/26 | ||
| Google Medical - Devices | TipRanks - Google | $394 | hold | 3.08%Upside | Initiated | 10/23/26 | ||
| Anthropic Medical - Devices | TipRanks - Anthropic | $386 | hold | 0.99%Upside | Initiated | 10/23/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | $392 | hold | 2.56%Upside | Initiated | 10/23/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | $373 | hold | -2.41%Downside | Initiated | 10/23/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | $394 | hold | 3.08%Upside | Initiated | 10/23/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/23/26 | $392 | hold | 2.56%Upside | Initiated | TipRanks - PerPlexity | ||
| Google Medical - Devices | 10/23/26 | $394 | hold | 3.08%Upside | Initiated | TipRanks - Google | ||
| Anthropic Medical - Devices | 10/23/26 | $386 | hold | 0.99%Upside | Initiated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/23/26 | $392 | hold | 2.56%Upside | Initiated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/23/26 | $373 | hold | -2.41%Downside | Initiated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/23/26 | $394 | hold | 3.08%Upside | Initiated | TipRanks - xAI |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BIO.B Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, BIO.B has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BIO.B average Analyst price target in the past 3 months is ―.
BIO.B Financial Forecast
High$2.29
Consensus$2.23
Low$2.16
BIO.B Earnings Forecast
Next quarter’s earnings estimate for BIO.B is $2.23 with a range of $2.16 to $2.29. The previous quarter’s EPS was $2.62. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$652M
Consensus$650M
Low$648M
BIO.B Sales Forecast
Next quarter’s sales forecast for BIO.B is $649.94M with a range of $647.80M to $652.08M. The previous quarter’s sales results were $651.00M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
BIO.B Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Bio-Rad Laboratories, Inc. Class B?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of BIO.B?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
